Matthew Szot
2022
In 2022, Matthew Szot earned a total compensation of $359.6K as Chief Financial Officer at Cadrenal Therapeutics.
Compensation breakdown
| Bonus | $187,500 |
|---|---|
| Other | $172,105 |
| Total | $359,605 |
Szot received $187.5K in bonus, accounting for 52% of the total pay in 2022.
Szot also received $172.1K in other compensation.
Rankings
In 2022, Matthew Szot's compensation ranked 4,870th out of 5,760 executives tracked by ExecPay. In other words, Szot earned more than 15.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,870 out of 5,760 | 16th |
Division Manufacturing | 2,700 out of 3,136 | 14th |
Major group Chemicals And Allied Products | 1,272 out of 1,422 | 11th |
Industry group Drugs | 1,197 out of 1,323 | 10th |
Industry Pharmaceutical Preparations | 876 out of 969 | 10th |
Source: SEC filing on June 11, 2024.
Szot's colleagues
We found two more compensation records of executives who worked with Matthew Szot at Cadrenal Therapeutics in 2022.